NICE guidance on bevacizumab in combination with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer.

Cite this paper

@article{Dyer2013NICEGO, title={NICE guidance on bevacizumab in combination with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer.}, author={Matthew Dyer and Joanna Richardson and J. Kirk Robertson and Jane E. Adam}, journal={The Lancet. Oncology}, year={2013}, volume={14 8}, pages={689-90} }